Perfil
Marina Udier currently works at Nouscom AG, as Chief Executive Officer & Director from 2020, Nouscom Srl, as Chief Executive Officer & Director, and Celyad Oncology SA, as Independent Director from 2011.
Dr. Udier also formerly worked at Novartis AG, as Head-Global Commercial and Versant Venture Management LLC, as Chief Operating Officer.
Dr. Udier received her doctorate degree from Yale University.
Cargos activos de Marina Udier
| Empresas | Cargo | Inicio |
|---|---|---|
| CELYAD ONCOLOGY SA | Director/Miembro de la Junta | 11/01/2011 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Director Ejecutivo | 01/05/2019 |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Director Ejecutivo | - |
Antiguos cargos conocidos de Marina Udier.
| Empresas | Cargo | Fin |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Director de Operaciones | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Formación de Marina Udier.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
- Bolsa de valores
- Insiders
- Marina Udier
















